Shares of Advanced Micro Devices (NASDAQ: AMD) have experienced a slight pullback at the start of 2026, with the stock being down approximately 8% year to date. This dip has caused some concern among investors, who are carefully considering the company’s high price-to-earnings multiple and the competitive risks it faces in the AI chip market, where Nvidia currently holds a dominant position.
Despite these challenges, investors may be overlooking the impressive surge in AMD’s free cash flow and what it signifies about the underlying strength of the business. In the fourth quarter alone, AMD’s free cash flow nearly doubled year over year to $2.1 billion, leading to a record full-year free cash flow of $5.5 billion. This growth was largely driven by the company’s thriving data center revenue.
During the fourth-quarter earnings call with analysts, CEO Lisa Su attributed AMD’s strong financial performance to the widespread demand for high-performance computing and AI products. The company reported a 34% year-over-year increase in revenue, with adjusted net income also rising by 42% to a record $2.5 billion.
Despite the challenges in the AI chip market, AMD’s surging free cash flow suggests that the company may be more competitively positioned than the current stock price reflects. While the shares are currently trading at 42 times 2026 free-cash-flow estimates, this valuation multiple drops to 16 on 2028 estimates.
Furthermore, AMD’s upcoming data center products, such as its Helios computing platform for AI workloads, have the potential to sustain growth in higher-margin products and continue the momentum of its free cash flow. This could make AMD a rewarding investment opportunity over the next several years.
See also Eliminating Waste, Fraud, and Abuse in Medicaid My Administration has been relentlessly committed to rooting out waste, fraud, and abuse in Government programs to preserve and protect them for those who rely most on them. The Medicaid program was designed to be a program to compassionately provide taxpayer dollars to healthcare providers who offer care to the most vulnerable Americans. To keep payments reasonable, billable costs for such care were historically capped at the same level that healthcare providers could receive from Medicare. The State and Federal Governments jointly shared this cost burden to ensure those of lesser means did not go untreated. Under the Biden Administration, States and healthcare providers were permitted to game the system. For example, States "taxed" healthcare providers, but sent the same money back to them in the form of a "Medicaid payment," which automatically unlocked for healthcare providers an additional "burden-sharing" payment from the Federal Government. Through this gimmick, the State could avoid contributing money toward Medicaid services, meaning the State no longer had a reason to be prudent in the amount of reimbursement provided. Instead of paying Medicare rates, many States that utilize these arrangements now pay the same healthcare providers almost three times the Medicare amount, a practice encouraged by the Biden Administration. These State Directed Payments have rapidly accelerated, quadrupling in magnitude over the last 4 years and reaching $110 billion in 2024 alone. This trajectory threatens the Federal Treasury and Medicaid's long-term stability, and the imbalance between Medicaid and Medicare patients threatens to jeopardize access to care for our seniors. I pledged to protect and improve these important Government healthcare programs for those that rely on them. Seniors on Medicare and Medicaid recipients both deserve access to quality care in a system free from the fraud, waste, and abuse, that enriches the unscrupulous and jeopardizes the programs themselves. We will take action to continue to love and cherish the Medicare and Medicaid programs to ensure they are preserved for those who need them most. The Secretary of Health and Human Services shall therefore take appropriate action to eliminate waste, fraud, and abuse in Medicaid, including by ensuring Medicaid payments rates are not higher than Medicare, to the extent permitted by applicable law. This memorandum is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person. DONALD J. TRUMP
Before making any investment decisions regarding Advanced Micro Devices, it is essential to carefully consider all factors at play. The Motley Fool Stock Advisor analyst team recently identified the 10 best stocks for investors to buy now, and AMD did not make the cut. However, the stocks that were selected have the potential to generate significant returns in the coming years.
It is worth noting that Stock Advisor’s total average return is an impressive 941%, significantly outperforming the S&P 500’s return of 194%. To stay updated on the latest top 10 list and join a community of individual investors, consider subscribing to Stock Advisor for valuable insights and investment opportunities.
